Clinical Trial Update: Pembrolizumab and Standard Therapy in Treating Patients With Glioblastoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing pembrolizumab with standard therapy for glioblastoma and gliosarcoma; status update indicates ongoing or completed results post…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma
• Gliosarcoma
• Supratentorial Glioblastoma

Drugs mentioned

• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: Mayo Clinic | Conditions: Glioblastoma, Gliosarcoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2026-03-25